Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T94048 | Target Info | |||
Target Name | Yes-associated protein 1 (YAP1) | ||||
Synonyms | Yorkie homolog; Yes-associated protein YAP65 homolog; YAP65; Transcriptional coactivator YAP1; Protein yorkie homolog; 65 kDa Yes-associated protein | ||||
Target Type | Literature-reported Target | ||||
Gene Name | YAP1 | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Auxiliary transporters | [+] 1 Auxiliary transporters | + | |||
Interacting Protein Name | 14-3-3 protein zeta/delta (YWHAZ) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | 14.3.3.zeta; HEL.S.3; HEL4; KCIP.1; YWHAD | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Fluorescence Resonance Energy Transfer | [3] | |||
Ester hydrolases | [+] 1 Ester hydrolases | + | |||
Interacting Target Name | Protein-tyrosine phosphatase pez (PTPN14) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine-protein phosphatase non-receptor type 14; PTPD2; PEZ | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [2] | |||
4 | Affinity Capture-MS | [5] | |||
5 | Affinity Capture-Western | [6] | |||
6 | Reconstituted Complex | [6] | |||
7 | Reconstituted Complex | [7] | |||
8 | Reconstituted Complex | [8] | |||
Kinases | [+] 4 Kinases | + | |||
Interacting Protein Name | Serine/threonine-protein kinase LATS1 (LATS1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | WARTS; wts | ||||
Evidence Score (E-score) | 12 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [2] | |||
4 | Affinity Capture-MS | [5] | |||
5 | Affinity Capture-Western | [9] | |||
6 | Affinity Capture-Western | [10] | |||
7 | Affinity Capture-Western | [11] | |||
8 | Affinity Capture-Western | [12] | |||
9 | Affinity Capture-Western | [13] | |||
10 | Affinity Capture-Western | [14] | |||
11 | Reconstituted Complex | [12] | |||
12 | Reconstituted Complex | [8] | |||
Interacting Target Name | Large tumor suppressor homolog 2 (LATS2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Warts-like kinase; Serine/threonine-protein kinase LATS2; Serine/threonine-protein kinase kpm; KPM; Kinase phosphorylated during mitosis protein | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [5] | |||
2 | Affinity Capture-Western | [9] | |||
3 | Affinity Capture-Western | [10] | |||
4 | Affinity Capture-Western | [15] | |||
5 | Biochemical Activity | [16] | |||
6 | Fluorescence Resonance Energy Transfer | [3] | |||
Interacting Target Name | Erbb4 tyrosine kinase receptor (Erbb-4) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine kinase-type cell surface receptor HER4; Receptor tyrosine-protein kinase erbB-4; Proto-oncogene-like protein c-ErbB-4; P180erbB4; HER4 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [17] | |||
2 | Co-localization | [18] | |||
3 | Reconstituted Complex | [8] | |||
4 | Yeast two hybrid | [19] | |||
Interacting Target Name | ERK activator kinase 1 (MEK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PRKMK1; MKK1; Mitogen-activated protein kinase kinase 1; MEK 1; MAPKK 1; MAPK/ERKkinase 1; MAPK/ERK kinase 1; MAP kinase kinase 1; Dual specificity mitogen-activated protein kinase kinase 1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Affinity Capture-Western | [20] | |||
Microtubule-associated | [+] 1 Microtubule-associated | + | |||
Interacting Protein Name | MAGUK p55 subfamily member 5 (MPP5) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PALS1 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [2] | |||
4 | Affinity Capture-MS | [5] | |||
5 | Proximity Label-MS | [1] | |||
Proteins 14-3-3 | [+] 3 Proteins 14-3-3 | + | |||
Interacting Target Name | AS1 14-3-3 protein eta (YWHAH) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | YWHA1; Protein AS1; 14-3-3 protein eta | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [2] | |||
4 | Affinity Capture-MS | [5] | |||
5 | Proximity Label-MS | [1] | |||
Interacting Protein Name | 14-3-3 protein gamma (YWHAG) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | 14.3.3GAMMA; PPP1R170 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [4] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Affinity Capture-MS | [5] | |||
4 | Fluorescence Resonance Energy Transfer | [3] | |||
5 | Proximity Label-MS | [1] | |||
Interacting Protein Name | 14-3-3 protein theta (YWHAQ) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | 14.3.3; 1C5; HS1 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [2] | |||
4 | Affinity Capture-MS | [5] | |||
5 | Affinity Capture-Western | [21] | |||
Transcription regulators | [+] 8 Transcription regulators | + | |||
Interacting Protein Name | Tumor protein p73 (TP73) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P73 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [22] | |||
2 | Affinity Capture-Western | [11] | |||
3 | Affinity Capture-Western | [23] | |||
4 | Affinity Capture-Western | [24] | |||
5 | Affinity Capture-Western | [25] | |||
6 | Affinity Capture-Western | [26] | |||
7 | Reconstituted Complex | [8] | |||
Interacting Protein Name | Transcriptional enhancer factor TEF-1 (TEAD1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AA; NTEF.1; REF1; TCF.13; TCF13; TEAD.1; TEF.1 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [5] | |||
2 | Affinity Capture-Western | [21] | |||
3 | Affinity Capture-Western | [5] | |||
4 | Co-localization | [5] | |||
5 | Proximity Label-MS | [1] | |||
Interacting Target Name | Mothers against decapentaplegic homolog 7 (SMAD7) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Smad7; SMAD family member 7; SMAD 7; Mothers against DPP homolog 8; Mothers against decapentaplegic homolog 8; MAD homolog 8; hSMAD7 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [27] | |||
2 | Co-crystal Structure | [28] | |||
3 | Reconstituted Complex | [8] | |||
4 | Yeast two hybrid | [27] | |||
Interacting Protein Name | Transcriptional enhancer factor TEF-5 (TEAD3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DTEF.1; ETFR.1; TEAD.3; TEAD5; TEF.5; TEF5 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [4] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Affinity Capture-MS | [5] | |||
4 | Proximity Label-MS | [1] | |||
Interacting Protein Name | Mad-related protein 1 (SMAD1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transforming growth factor-beta-signaling protein 1; Smad1; SMAD family member 1; SMAD 1; Mothers against DPP homolog 1; Mothers against decapentaplegic homolog 1; Mad-related protein 1; MADR1; MADH1; MAD homolog 1; JV4-1; BSP-1; BSP1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [29] | |||
2 | Co-crystal Structure | [30] | |||
3 | Reconstituted Complex | [30] | |||
Interacting Protein Name | Runt-related transcription factor 1 (RUNX1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AML1; AML1.EVI.1; AMLCR1; CBFA2; EVI.1; PEBP2aB | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [31] | |||
2 | Reconstituted Complex | [8] | |||
3 | Yeast two hybrid | [32] | |||
Interacting Target Name | Signal transducer and activator of transcription 1 (STAT1) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor ISGF-3 components p91/p84; STAT-1; Signal transducers and activators of transcription factor; Signal transducer and activator of transcription 1-alpha/beta; P91 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Co-fractionation | [33] | |||
Interacting Target Name | Runt-related transcription factor 2 (RUNX2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SL3-3 enhancer factor 1 alpha A subunit; SL3/AKV core-binding factor alpha A subunit; Polyomavirus enhancer-binding protein 2 alpha Asubunit; Polyomavirus enhancer-binding protein 2 alpha A subunit; PEBP2-alpha A; PEBP2A; PEA2-alpha A; Osteoblast-specific transcription factor 2; OSF-2; OSF2; Oncogene AML-3; Core-binding factor subunit alpha-1; CBF-alpha-1; CBFA1; AML3; Acute myeloid leukemia 3 protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Reconstituted Complex | [32] | |||
Other proteins | [+] 11 Other proteins | + | |||
Interacting Protein Name | Apoptosis-stimulating of p53 protein 2 (TP53BP2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | 53BP2; ASPP2; BBP; P53BP2; PPP1R13A | ||||
Evidence Score (E-score) | 9 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [2] | |||
4 | Affinity Capture-MS | [5] | |||
5 | Far Western | [34] | |||
6 | Protein-peptide | [34] | |||
7 | Proximity Label-MS | [1] | |||
8 | Reconstituted Complex | [35] | |||
9 | Yeast two hybrid | [35] | |||
Interacting Target Name | Angiomotin (AMOT) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | KIAA1071 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-Western | [36] | |||
4 | Affinity Capture-Western | [37] | |||
5 | Reconstituted Complex | [38] | |||
Interacting Protein Name | Angiomotin-like protein 2 (AMOTL2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | LCCP | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [2] | |||
4 | Affinity Capture-MS | [5] | |||
5 | Proximity Label-MS | [1] | |||
Interacting Protein Name | InaD-like protein (PATJ) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Cipp; InaD.like; PATJ; hINADL | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [2] | |||
4 | Affinity Capture-MS | [5] | |||
5 | Proximity Label-MS | [1] | |||
Interacting Protein Name | Angiomotin-like protein 1 (AMOTL1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | JEAP | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [5] | |||
4 | Proximity Label-MS | [1] | |||
Interacting Protein Name | Multiple PDZ domain protein (MPDZ) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HYC2; MUPP1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [5] | |||
4 | Proximity Label-MS | [1] | |||
Interacting Protein Name | WW domain-binding protein 2 (WBP2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | WBP.2 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [2] | |||
4 | Reconstituted Complex | [8] | |||
Interacting Protein Name | AT-rich interactive domain-containing protein 1A (ARID1A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | B120; BAF250; BAF250a; BM029; C1orf4; ELD; MRD14; OSA1; P270; SMARCF1; hELD; hOSA1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [5] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Proximity Label-MS | [1] | |||
Interacting Protein Name | Ras association domain-containing protein 8 (RASSF8) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | C12orf2; HOJ1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Proximity Label-MS | [1] | |||
Interacting Protein Name | Zinc finger protein ubi-d4 (DPF2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | REQ; UBID4; ubi.d4 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [5] | |||
2 | Proximity Label-MS | [1] | |||
Interacting Protein Name | WW domain-binding protein 1 (WBP1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | WBP.1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Protein-peptide | [39] | |||
2 | Reconstituted Complex | [8] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions. Sci Signal. 2013 Nov 19;6(302):rs15. | ||||
REF 2 | Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in -Catenin-Active Cancers. Cell Syst. 2016 Sep 28;3(3):302-316.e4. | ||||
REF 3 | OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc. Oncogene. 2017 Oct 19;36(42):5852-5860. | ||||
REF 4 | Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1. Mol Syst Biol. 2013 Dec 22;9:713. | ||||
REF 5 | Aerobic glycolysis tunes YAP/TAZ transcriptional activity. EMBO J. 2015 May 12;34(10):1349-70. | ||||
REF 6 | PTPN14 is required for the density-dependent control of YAP1. Genes Dev. 2012 Sep 1;26(17):1959-71. | ||||
REF 7 | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. Mol Cell Proteomics. 2016 Sep;15(9):3030-44. | ||||
REF 8 | Ligand binding to WW tandem domains of YAP2 transcriptional regulator is under negative cooperativity. FEBS J. 2014 Dec;281(24):5532-51. | ||||
REF 9 | Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. Cancer Res. 2008 Apr 15;68(8):2789-94. | ||||
REF 10 | Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP. Genes Dev. 2010 Nov 1;24(21):2430-9. | ||||
REF 11 | Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). J Biol Chem. 2008 Oct 10;283(41):27534-46. | ||||
REF 12 | Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem. 2008 Feb 29;283(9):5496-509. | ||||
REF 13 | RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell. 2007 Sep 21;27(6):962-75. | ||||
REF 14 | RAR Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway. Cancer Res. 2016 Jul 1;76(13):3813-25. | ||||
REF 15 | Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73. Blood. 2008 Nov 1;112(9):3856-66. | ||||
REF 16 | Hippo pathway-dependent and -independent roles of RASSF6. Sci Signal. 2009 Sep 29;2(90):ra59. | ||||
REF 17 | The E3 ubiquitin ligase WWP1 selectively targets HER4 and its proteolytically derived signaling isoforms for degradation. Mol Cell Biol. 2009 Feb;29(3):892-906. | ||||
REF 18 | WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem. 2003 Aug 29;278(35):33334-41. | ||||
REF 19 | Ligand-regulated association of ErbB-4 to the transcriptional co-activator YAP65 controls transcription at the nuclear level. Exp Cell Res. 2004 Apr 1;294(2):469-79. | ||||
REF 20 | MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer. FEBS Lett. 2013 Dec 11;587(24):3921-7. | ||||
REF 21 | Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012 Aug 17;150(4):780-91. | ||||
REF 22 | The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73. Cell Death Differ. 2007 Apr;14(4):743-51. | ||||
REF 23 | The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage. Mol Cell. 2005 May 13;18(4):447-59. | ||||
REF 24 | PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol Cell. 2008 Dec 26;32(6):803-14. | ||||
REF 25 | Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell. 2008 Feb 15;29(3):350-61. | ||||
REF 26 | TGF- Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP/SMAD2 Nuclear Translocation. Mol Cell. 2016 Jul 7;63(1):156-66. | ||||
REF 27 | Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling. Oncogene. 2002 Jul 25;21(32):4879-84. | ||||
REF 28 | Structural basis for the versatile interactions of Smad7 with regulator WW domains in TGF- Pathways. Structure. 2012 Oct 10;20(10):1726-36. | ||||
REF 29 | Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell. 2009 Nov 13;139(4):757-69. | ||||
REF 30 | A Smad action turnover switch operated by WW domain readers of a phosphoserine code. Genes Dev. 2011 Jun 15;25(12):1275-88. | ||||
REF 31 | A regulatory circuit controlling Itch-mediated p73 degradation by Runx. J Biol Chem. 2008 Oct 10;283(41):27462-8. | ||||
REF 32 | A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J. 1999 May 4;18(9):2551-62. | ||||
REF 33 | A high-throughput approach for measuring temporal changes in the interactome. Nat Methods. 2012 Sep;9(9):907-9. | ||||
REF 34 | A single point mutation in a group I WW domain shifts its specificity to that of group II WW domains. J Biol Chem. 1999 Jun 11;274(24):17284-9. | ||||
REF 35 | Yes-associated protein and p53-binding protein-2 interact through their WW and SH3 domains. J Biol Chem. 2001 Apr 27;276(17):14514-23. | ||||
REF 36 | Amot130 adapts atrophin-1 interacting protein 4 to inhibit yes-associated protein signaling and cell growth. J Biol Chem. 2013 May 24;288(21):15181-93. | ||||
REF 37 | Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases. Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17368-73. | ||||
REF 38 | The Nedd4-like ubiquitin E3 ligases target angiomotin/p130 to ubiquitin-dependent degradation. Biochem J. 2012 Jun 1;444(2):279-89. | ||||
REF 39 | The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1. Mol Cell Biol. 2001 Nov;21(22):7617-28. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.